EGFR and breast cancer: Previous studies have also reported that Se/FO supplements target EGFR/TβR/AXL/PI3K/Akt/mTOR signaling and therefore increase the apoptotic efficacy of anti-cancer agents in breast-cancer-bearing mice and NSCLC cells [17,27].